NYLIM
IRWD icon

New York Life Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

New York Life Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-45,091
Closed -$559K – 1294
2022
Q4 		$559K Buy
45,091
+5,083
+13% +$57.7K 0.01% 834
2022
Q3 		$414K Buy
40,008
+2,938
+8% +$33.3K 0.01% 920
2022
Q2 		$427K Buy
+37,070
New +$437K 0.01% 870

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

New York Life Investment Management's IRWD Position: Q1 2023 in Review

New York Life Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2023, closing a stake of 45,091 shares — an estimated $559K sold.

New York Life Investment Management first reported a position in IRWD in Q2 2022 and held it in 3 quarters. The position peaked at $559K in Q4 2022. 254 funds tracked by Wall St. Rank hold IRWD as of Q1 2023.

  • New York Life Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • New York Life Investment Management sold 45,091 Ironwood Pharmaceuticals shares in Q1 2023, an estimated $559K.
  • New York Life Investment Management first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 3 quarters.
  • New York Life Investment Management's Ironwood Pharmaceuticals position peaked at $559K in Q4 2022.
  • 254 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2023.

Based on New York Life Investment Management's 13F filing for Q1 2023, filed 8 May 2023.